Article info

Download PDFPDF

Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells

Authors

  1. a i.johanna{at}umcutrecht.nl
  2. b g.c.m.straetemans{at}umcutrecht.nl
  3. c s.heijhuurs{at}umcutrecht.nl
  4. d t.aarts{at}umcutrecht.nl
  5. e haakannorell{at}gmail.com
  6. f l.bongiovanni{at}uu.nl
  7. g A.deBruin{at}uu.nl
  8. h z.sebestyen{at}umcutrecht.nl
  9. i +31 (0)88 75 59030 j.h.e.kuball{at}umcutrecht.nl
View Full Text

Citation

Johanna I, Straetemans T, Heijhuurs S, et al
Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells

Publication history

  • Received August 17, 2018
  • Accepted March 4, 2019
  • First published March 12, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.